Search

Search Constraints

You searched for: Author/Creator Mielke, O.

Search Results

1. 20. Practical application of subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy – results from a multicenter, randomized, double-blind, placebo-controlled trial (The PATH Study). Issue 3 (March 2020)

2. Feasibility of switching from intravenous to subcutaneous immunoglobulin in CIDP: PATH trial and clinical experience. Issue 1 (January 2019)

3. Patient‐reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH study. (23rd September 2019)

4. Subcutaneous immunoglobulin (SCIG) for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: The PATH Study. Issue 1 (January 2019)